Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate

Joint Bone Spine

Volumn 77, Issue 1, 2010, Pages 70-72

  Slimani, Samy ^a   Abdessemed, Amina ^a   Haddouche, Assia ^a   Ladjouze Rezig, Aicha ^a  

^a Ben Aknoun Hospital   (Algeria)

Author keywords

Bisphosphonates; Dermatomyositis; Diffuse calcinosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CALCIUM; COLCHICINE; COLECALCIFEROL; CORTICOSTEROID; METHYLPREDNISOLONE; MUSCLE ENZYME; PAMIDRONIC ACID;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CALCINOSIS; CASE REPORT; DERMATOMYOSITIS; DRUG EFFICACY; ELECTROMYOGRAM; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; JUVENILE DERMATOMYOSITIS; MUSCLE BIOPSY; MYALGIA; TREATMENT OUTCOME; ULCER;

ADOLESCENT; BONE DENSITY CONSERVATION AGENTS; CALCINOSIS; CALCIUM; CHOLECALCIFEROL; DERMATOMYOSITIS; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METHYLPREDNISOLONE; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 73449093782     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.04.011     Document Type: Article

References (14)

1. Packman L.M. Juvenile dermosynovitis, pathophysiology and disease expression. Pediatr Clin North Am 42 (1995) 1071-1098
2. Nakamura H. Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis. J Rheumatol 33 (2006) 1691-1693
3. Skuterud E. Calcinosis in dermatomyositis treated with probenecid. Scand J Rheumatol 10 (1981) 92-94
4. Wang W.J. Calcinosis cutis in juvenile dermatomyositis: Remarkable response to aluminium hydroxide therapy. Arch Dermatol 124 (1988) 1721-1722
5. Palmieri G.M.A. Treatment of calcinosis with diltiazem. Arthritis Rheum 38 (1995) 1646-1654
6. Oliveri M.B. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 23 (1996) 2152-2155
7. Yang M.C. Improvement of juvenile dermatomyositis with calcinosis universalis after treatment with intravenous immunoglobulin. Int J Rheum Dis 11 (2008) 77-80
8. Mukamel M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 138 (2001) 763-766
9. Ambler G.R. Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy. J Rheumatol 32 (2005) 1837-1839
10. Riley P. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology 47 (2008) 877-880
11. Rider L. Elevations of interleukin-1 receptor antagonist (Il1RA), STNFR. S1L2R, and IL-10 in juvenile idiopathic inflammatory myopathies suggest a role for monocyte/macrophage and B lymphocyte anti-radium. Arthritis Rheum 41 (1998) S265
12. Murphy E. Evidence for increased bone turnover in patients with dystrophic calcification. Arthritis Rheum 39 (1996) S97
13. Metzger A.L. Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. N Engl J Med 291 (1974) 1294-1296
14. Bianchi M.L. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum 43 (2000) 1960-1966